Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects.
about
Realistic expectations of prepulse inhibition in translational models for schizophrenia research.Antipsychotic-like effects of a neurotensin receptor type 1 agonist.Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.Systemic administration of the neurotensin NTS₁-receptor agonist PD149163 improves performance on a memory task in naturally deficient male brown Norway ratsElucidating the role of neurotensin in the pathophysiology and management of major mental disorders.The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle.Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacyPredictive animal models of mania: hits, misses and future directions.Clozapine and PD149163 elevate prepulse inhibition in Brown Norway rats.Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69LEffects of neurotensin-2 receptor deletion on sensorimotor gating and locomotor activityChronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing toleranceSensorimotor gating in neurotensin-1 receptor null mice.Endogenous neurotensin is involved in estrous cycle related alterations in prepulse inhibition of the acoustic startle reflex in female ratsActivation of neurotensin receptor 1 facilitates neuronal excitability and spatial learning and memory in the entorhinal cortex: beneficial actions in an Alzheimer's disease modelPromise and pitfalls of animal models of schizophreniaNeurobiology of sociability.Patterns of Spontaneous Local Network Activity in Developing Cerebral Cortex: Relationship to Adult Cognitive Function.Neurotensin agonists as an alternative to antipsychotics.The role of neurotensin in central nervous system pathophysiology: what is the evidence?The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance.Effects of the neurotensin NTS₁ receptor agonist PD149163 on visual signal detection in rats.The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperature.The brattleboro rat displays a natural deficit in social discrimination that is restored by clozapine and a neurotensin analog.The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats.Prepulse inhibition deficits in GAD65 knockout mice and the effect of antipsychotic treatment.Further neurochemical and behavioural investigation of Brattleboro rats as a putative model of schizophrenia.Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: reversal by antipsychotic drugs.Antipsychotic drug-like facilitation of latent inhibition by a brain-penetrating neurotensin-1 receptor agonist.
P2860
Q24645703-6006137E-5CB8-4644-A5DF-0F4F7AE1BF2CQ30356261-71B1E7F9-3DD2-4306-8316-0D82FE30BAD5Q30395034-0688DCFA-3D21-4278-B52A-A57B2A51F4A9Q30397210-B0BE5D1B-61CF-4C02-99CA-5EE03FBF4A3AQ30426586-9F5E1C21-D3C0-4499-B1F5-10C6DF917B68Q30427365-F3CBF960-4178-469C-A228-53B3A32D7E97Q30427588-755D0B8B-9172-4CC3-BE84-0C4A79662C21Q30462823-EC889ED2-65B7-481E-8081-299A01281FB4Q30468932-B5DBE69F-1560-40F1-A99E-55B32546301EQ30472097-9A81BB43-A1DB-472F-99EF-A34B0674C55CQ30473715-CA9638C4-F350-4B2A-A5AC-39D12D616514Q30477036-48235465-0C35-49F2-A760-628ACEB8728CQ30477911-B64B6FFF-5ACF-4AF4-8B67-600F46F18857Q30491584-37566692-98E2-43D4-8D3B-801AC8C0C70FQ33605826-9BE3ED11-01C4-4BA9-BEE2-E31FE58C3CE2Q33956579-E5F24BFB-8FD3-4952-905D-14D467EF5485Q34096686-FA1D0356-60B9-4545-8200-C9804A27B31DQ35670926-1624B9B0-FA64-4446-A321-F031A9DC11DCQ36120748-3438CD67-CFCA-4C3D-825E-A1C7379CD51DQ36544566-0EAC20E0-988B-4E14-BF51-C70BA68990F7Q37370136-6205B851-4DA7-49AE-9570-CBBABA6CBE1EQ37389307-FD11FF77-47E4-4ACC-8099-5C4D0BE0AF48Q37442045-420D77A0-BA8A-4848-B80A-D8A693DF9C55Q41879506-0DDCD471-3320-4158-B4C9-4FF2A7402AC2Q42750368-988873A6-70AC-4D61-B530-CE876B138AA1Q44870037-7FAF6B04-1EFF-4E8D-BDC2-96E6D6BF0E37Q46127896-A43EAC1B-085A-4960-8C0B-7CCFA2AA40B3Q46547612-F1362759-D2D6-43B4-96E3-100D079D5576Q48966975-45C02AAE-8890-4DD4-BA4A-B6F9B9E53FB0
P2860
Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Reversal of sensorimotor gatin ...... r novel antipsychotic effects.
@en
Reversal of sensorimotor gatin ...... r novel antipsychotic effects.
@nl
type
label
Reversal of sensorimotor gatin ...... r novel antipsychotic effects.
@en
Reversal of sensorimotor gatin ...... r novel antipsychotic effects.
@nl
prefLabel
Reversal of sensorimotor gatin ...... r novel antipsychotic effects.
@en
Reversal of sensorimotor gatin ...... r novel antipsychotic effects.
@nl
P2093
P2860
P356
P1476
Reversal of sensorimotor gatin ...... r novel antipsychotic effects.
@en
P2093
David Feifel
Gilia Melendez
Paul D Shilling
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300378
P407
P577
2004-04-01T00:00:00Z